Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for emergence in elderly hip replacement
NCT06513923Phase 4Completed
- Sponsor
- Central South University
- Start
- Feb 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in hip fracture (3 arms), sponsored by Central South University. Primary endpoint: Time to Emergence at 1 day. Started Feb 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT06513923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06513923.